Thrivent Financial for Lutherans Sells 29,597 Shares of CVS Health Co. (NYSE:CVS)

Thrivent Financial for Lutherans reduced its position in CVS Health Co. (NYSE:CVS) by 19.3% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 123,551 shares of the pharmacy operator’s stock after selling 29,597 shares during the period. Thrivent Financial for Lutherans’ holdings in CVS Health were worth $7,297,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of the company. Ables Iannone Moore & Associates Inc. purchased a new position in CVS Health during the 4th quarter worth $32,000. Creekmur Asset Management LLC acquired a new stake in CVS Health in the 4th quarter worth approximately $34,000. Steph & Co. grew its position in CVS Health by 192.0% during the 1st quarter. Steph & Co. now owns 438 shares of the pharmacy operator’s stock worth $35,000 after purchasing an additional 288 shares during the last quarter. Kapitalo Investimentos Ltda acquired a new position in CVS Health during the 4th quarter valued at approximately $36,000. Finally, Scarborough Advisors LLC purchased a new position in shares of CVS Health in the fourth quarter worth $37,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Trading Up 0.6 %

NYSE CVS opened at $59.02 on Friday. CVS Health Co. has a 52 week low of $52.77 and a 52 week high of $83.25. The firm has a 50 day moving average of $58.18 and a two-hundred day moving average of $62.17. The stock has a market capitalization of $74.09 billion, a PE ratio of 10.37, a price-to-earnings-growth ratio of 0.81 and a beta of 0.53. The company has a quick ratio of 0.66, a current ratio of 0.86 and a debt-to-equity ratio of 0.83.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. The company had revenue of $91.23 billion for the quarter, compared to analysts’ expectations of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. CVS Health’s quarterly revenue was up 2.6% on a year-over-year basis. During the same period last year, the firm earned $2.21 earnings per share. As a group, research analysts expect that CVS Health Co. will post 6.51 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Stockholders of record on Monday, October 21st will be given a dividend of $0.665 per share. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.51%. CVS Health’s dividend payout ratio is presently 46.75%.

Analyst Ratings Changes

Several research firms have weighed in on CVS. Cantor Fitzgerald reiterated a “neutral” rating and set a $62.00 price target on shares of CVS Health in a research note on Monday, September 16th. Wells Fargo & Company increased their price target on CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a research report on Monday, August 12th. JPMorgan Chase & Co. decreased their price objective on CVS Health from $101.00 to $86.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Baird R W raised CVS Health to a “hold” rating in a report on Thursday, May 30th. Finally, Royal Bank of Canada reissued an “outperform” rating and issued a $68.00 price target on shares of CVS Health in a report on Wednesday, September 4th. Eleven research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $72.10.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.